1. Home
  2. CRUS vs PCVX Comparison

CRUS vs PCVX Comparison

Compare CRUS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

HOLD

Current Price

$173.62

Market Cap

8.7B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$59.35

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRUS
PCVX
Founded
1984
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
9.0B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CRUS
PCVX
Price
$173.62
$59.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$157.00
$88.25
AVG Volume (30 Days)
631.7K
1.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
22.45
N/A
EPS
6.27
N/A
Revenue
$1,896,077,000.00
N/A
Revenue This Year
$7.12
N/A
Revenue Next Year
$0.49
N/A
P/E Ratio
$27.52
N/A
Revenue Growth
5.99
N/A
52 Week Low
$91.32
$28.09
52 Week High
$173.84
$65.00

Technical Indicators

Market Signals
Indicator
CRUS
PCVX
Relative Strength Index (RSI) 76.93 49.66
Support Level $115.31 $52.04
Resistance Level N/A $64.16
Average True Range (ATR) 4.76 2.20
MACD 1.23 -0.21
Stochastic Oscillator 92.88 17.50

Price Performance

Historical Comparison
CRUS
PCVX

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: